Ignite Creation Date:
2024-05-05 @ 9:19 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00856856
Status:
COMPLETED
Last Update Posted:
2019-02-07
First Post:
2009-02-27
Brief Title:
ABSORB Clinical Investigation Cohort B
Sponsor:
Abbott Medical Devices
Organization:
Abbott Medical Devices
Study Overview
Official Title:
A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System BVS EECSS in the Treatment of Patients With de Novo Native Coronary Artery Lesions
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ABSORB B
Brief Summary:
The purpose of this study is to assess the safety and performance of the BVS Everolimus Eluting Coronary Stent System EECSS in the treatment of patients with a maximum of two de novo native coronary artery lesions located in two different major epicardial vessels
Currently in development at Abbott Vascular Not available for sale in the United States
Currently in development at Abbott Vascular Not available for sale in the United States
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None